newsfilter
← Latest News
GlobeNewswire·

Checkmate Pharmaceuticals Appoints Alan Bash as President and CEO

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) ("Checkmate"), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to co